Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
WEST CHESTER, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a medical device company and a leader in the development of technologies and solutions for the treatment of atrial fibrillation, or Afib, and systems for the exclusion of the left atrial appendage, today announced financial results for the first quarter of 2013.
“Our first quarter results reflect double digit revenue growth, balanced globally. We are starting to see the results of our training and education efforts in capturing market share,” said Mike Carrel, President and Chief Executive Officer of AtriCure.
Help employers find you! Check out all the jobs and post your resume.